SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $443,000 | +1.8% | 39,519 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $435,000 | +12.4% | 39,519 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $387,000 | -9.4% | 39,519 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $427,000 | +12.1% | 39,519 | +6.4% | 0.00% | 0.0% |
Q3 2016 | $381,000 | -26.9% | 37,130 | -6.9% | 0.00% | -25.0% |
Q2 2016 | $521,000 | +15.8% | 39,870 | -2.5% | 0.00% | +33.3% |
Q1 2016 | $450,000 | +24.3% | 40,890 | +3.9% | 0.00% | 0.0% |
Q4 2015 | $362,000 | +32.6% | 39,372 | 0.0% | 0.00% | +50.0% |
Q3 2015 | $273,000 | -31.1% | 39,372 | -2.4% | 0.00% | -33.3% |
Q2 2015 | $396,000 | +2.6% | 40,336 | -7.4% | 0.00% | 0.0% |
Q1 2015 | $386,000 | +0.3% | 43,546 | -0.9% | 0.00% | 0.0% |
Q4 2014 | $385,000 | +27.1% | 43,949 | 0.0% | 0.00% | +50.0% |
Q3 2014 | $303,000 | +163.5% | 43,949 | +100.4% | 0.00% | +100.0% |
Q2 2014 | $115,000 | -48.0% | 21,935 | -54.8% | 0.00% | -50.0% |
Q1 2014 | $221,000 | -9.4% | 48,489 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $244,000 | -0.8% | 48,489 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $246,000 | +5.1% | 48,489 | +2.7% | 0.00% | 0.0% |
Q2 2013 | $234,000 | – | 47,217 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |